• Home Blog Tag Acute myeloid leukemia market

Acute Myeloid Leukemia market

Jun 03, 2025

Beam’s BEAM-302 Earns FDA Orphan Drug Tag for AATD; Incannex’s IHL-42X Moves to Phase III After FDA Protocol OK; Kura and Kyowa Kirin’s Ziftomenib Gets FDA Priority Review in NPM1-Mutant AML; GSK’s Linerixibat NDA Accepted by FDA for PBC-Linked Pruritus; Ascendis’ TransCon CNP Granted FDA Priority Review for Achondroplasia

Feb 10, 2025

Acute Myeloid Leukemia: The Battle, The Breakthroughs, The Future

Newsletter/Whitepaper